Phreesia PE Ratio 2019-2025 | PHR

Current and historical p/e ratio for Phreesia (PHR) from 2019 to 2025. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Phreesia PE ratio as of June 06, 2025 is 0.00.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.

Phreesia PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2025-06-06 26.81 0.00
2025-04-30 24.96 $-0.67 0.00
2025-01-31 28.46 $-1.02 0.00
2024-10-31 18.29 $-1.47 0.00
2024-07-31 24.95 $-1.80 0.00
2024-04-30 20.74 $-2.17 0.00
2024-01-31 25.48 $-2.52 0.00
2023-10-31 13.66 $-2.68 0.00
2023-07-31 31.72 $-2.86 0.00
2023-04-30 31.64 $-3.07 0.00
2023-01-31 37.49 $-3.36 0.00
2022-10-31 27.32 $-3.54 0.00
2022-07-31 23.49 $-3.49 0.00
2022-04-30 22.88 $-3.08 0.00
2022-01-31 31.19 $-2.33 0.00
2021-10-31 70.54 $-1.61 0.00
2021-07-31 68.35 $-1.07 0.00
2021-04-30 51.75 $-0.76 0.00
2021-01-31 65.29 $-0.68 0.00
2020-10-31 36.97 $-0.60 0.00
2020-07-31 30.06 $-0.50 0.00
2020-04-30 25.39 $-10.75 0.00
Sector Industry Market Cap Revenue
Medical Medical Information Systems $1.595B $0.420B
Phreesia Inc. provides a patient intake management platform. The company's SaaS platform engages patients in their care and provides a modern, consistent experience, while enabling healthcare organizations to optimize their staffing, boost profitability and enhance clinical care. Phreesia Inc. is based in New York.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $46.427B 59.33
Hims & Hers Health (HIMS) United States $12.608B 131.00
Tempus AI (TEM) United States $10.745B 0.00
IRhythm Technologies (IRTC) United States $4.683B 0.00
Inspire Medical Systems (INSP) United States $4.012B 62.68
Hinge Health (HNGE) United States $3.034B 0.00
Privia Health (PRVA) United States $2.827B 193.25
Enovis (ENOV) United States $1.816B 10.12
Schrodinger (SDGR) United States $1.807B 0.00
Clover Health Investments (CLOV) United States $1.555B 0.00
Omnicell (OMCL) United States $1.452B 25.62
Azenta (AZTA) United States $1.316B 61.17
10x Genomics (TXG) United States $1.160B 0.00
Fulgent Genetics (FLGT) United States $0.652B 0.00
Claritev (CTEV) United States $0.650B 0.00
Butterfly Network (BFLY) United States $0.613B 0.00
Talkspace (TALK) United States $0.550B 164.50
Veradigm (MDRX) United States $0.476B 0.00
Standard BioTools (LAB) United States $0.403B 0.00
Outset Medical (OM) United States $0.371B 0.00
TruBridge (TBRG) United States $0.358B 794.00
Health Catalyst (HCAT) United States $0.285B 0.00
Nyxoah SA (NYXH) Belgium $0.261B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.209B 0.00
KORU Medical Systems (KRMD) United States $0.142B 0.00
EUDA Health Holdings (EUDA) Singapore $0.128B 0.00
Pulmonx (LUNG) United States $0.128B 0.00
American Well (AMWL) United States $0.109B 0.00
MDxHealth SA (MDXH) Belgium $0.098B 0.00
CareCloud (CCLD) United States $0.092B 3.52
111 (YI) China $0.073B 0.00
HeartBeam (BEAT) United States $0.056B 0.00
P3 Health Partners (PIII) United States $0.048B 0.00
Zepp Health (ZEPP) Netherlands $0.034B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.031B 0.00
Zhongchao (ZCMD) China $0.027B 0.00
Streamline Health Solutions (STRM) United States $0.022B 0.00
Precipio (PRPO) United States $0.017B 0.00
Bullfrog AI Holdings (BFRG) United States $0.016B 0.00
MSP Recovery (MSPR) United States $0.012B 0.00
Strata Skin Sciences (SSKN) United States $0.010B 0.00
Predictive Oncology (POAI) United States $0.008B 0.00
Movano (MOVE) United States $0.005B 0.00
Evaxion - (EVAX) Denmark $0.004B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.004B 0.00
HeartSciences (HSCS) United States $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.003B 0.00
Healthcare Triangle (HCTI) United States $0.000B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00